Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes-Reference-Cited by-同舟云学术

Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes

Published:2011 Issue:2 Volume:26 Page:153
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Lee Jinwoo¹,Lee Chang-Hoon²,Kim Deog Kyeom²,Yoon Ho Il³,Kim Jae Yeol⁴,Lee Sang-Min¹,Yang Seok-Chul¹,Lee Jae Ho³,Yoo Chul-Gyu¹,Lee Choon-Taek³,Chung Hee Soon²,Kim Young Whan¹,Han Sung Koo¹,Yim Jae-Joon¹

Affiliation:

1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National University College of Medicine, Seoul, Korea.

2. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.

3. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

4. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.

Publisher

Korean Association of Internal Medicine

Link

http://synapse.koreamed.org/pdf/10.3904/kjim.2011.26.2.153

Reference30 articles.

1. The Role of Fluoroquinolones in Tuberculosis Today

2. New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development

3. Fluoroquinolones for the Treatment of Pulmonary Tuberculosis

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea;The Lancet;2022-10

2. The treatment effect of Levofloxacin, Moxifloxacin, and Gatifloxacin contained in the conventional therapy regimen for pulmonary tuberculosis: Systematic review and network meta-analysis;Medicine;2022-09-23

3. Advances in Treatment of Drug-Resistant Pulmonary TB: What Is the Latest Approach to Treat Drug-Resistant Pulmonary TB?;Respiratory Disease Series: Diagnostic Tools and Disease Managements;2022

4. Temporal trends of pharmacologic treatments for tuberculosis and multidrug resistant tuberculosis following dissemination of treatment guidelines in South Korea;Journal of Microbiology, Immunology and Infection;2021-11

5. Meta-analysis on Effectiveness and Safety of Moxifloxacin in Treatment of Multidrug Resistant Tuberculosis in Adults;Medicine;2020-06-19